2010 annual financial data
Anika Therapeutics 2010 Operating cash flow margin
Direct answer
Operating cash flow margin was 14.14%.
Operating income was 7,537,686 USD and net income was 4,315,995 USD.
Operating cash flow was 7,853,461 USD.
Get free Anika Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 55,556,594 USD
- Operating income
- 7,537,686 USD
- Net income
- 4,315,995 USD
- Operating cash flow
- 7,853,461 USD